FDA Adverse Event Malfunction Summary report: N

AESPIRE 100

MDR report key: 3770340 · Received February 18, 2014

Report

Report Number
9710602-2014-00002
Event Type
Malfunction
Date Received
February 18, 2014
Date of Event
August 6, 2013
Report Date
October 8, 2013
Manufacturer
GE MEDICAL SYSTEMS (CHINA) CO., LTD.
Product Code
BSZ
PMA / PMN Number
K973896
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THIS MALFUNCTION WAS DETERMINED TO BE REPORTABLE AS THIS SAME MALFUNCTION HAS PREVIOUSLY CONTRIBUTED TO A SERIOUS INJURY WITHIN THE LAST TWO YEARS. REFERENCE MDR 2112667-2013-00005. THE DISTRIBUTOR PERFORMED A CHECKOUT OF THE EQUIPMENT AND NOTED THAT THE FLOW SENSOR DIAPHRAGM WAS STUCK OPEN. MANUAL MODE OF VENTILATION IS AVAILABLE TO MAINTAIN VENTILATION OF THE PT. FLOW SENSORS OF THIS TYPE ARE CUSTOMER REPLACEABLE, ARE RECOMMENDED FOR REPLACEMENT AFTER 3 MONTHS, AND ARE WARRANTED FOR 6 MONTHS. THE MAINTENANCE SCHEDULE IN THE USER REFERENCE MANUAL STATES: "REPLACE THE DISPOSABLE FLOW SENSOR (PLASTIC). UNDER TYPICAL USE, THE SENSOR MEETS SPECIFICATIONS FOR A MINIMUM OF 3 MONTHS." IN ENGINEERING EVAL, THE STUCK DIAPHRAGM HAS BEEN ABLE TO BE REPRODUCED BY: A HARD IMPACT, SUCH AS DROPPING THE FLOW SENSOR, OR BY STICKING AN OBJECT INTO THE FLOW SENSOR, CAUSING THE DIAPHRAGM TO STICK OPEN. IF A SENSOR IS SUBJECTED TO A HARD IMPACT, IT IS STILL UNLIKELY THAT THE DIAPHRAGM WILL GET STUCK IN THE OPEN POSITION. THIS FAILURE MODE REQUIRES AN IMPACT IN A VERY LIMITED ORIENTATION TO RESULT IN THE INERTIA NEEDED TO FORCE THE DIAPHRAGM INTO THE STUCK OPEN POSITION.

Description of Event or Problem · 1

DURING A PREOPERATIVE CHECKOUT OF THE EQUIPMENT, THE HOSPITAL REPORTEDLY NOTED SET TIDAL VOLUME WAS 500 ML AND DELIVERED TIDAL VOLUME WAS 350 ML. THERE WAS NO PT INVOLVEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
101153 AESPIRE 100 ANESTHESIA GAS MACHINE BSZ GE MEDICAL SYSTEMS (CHINA) CO., LTD.

Patients

Seq Age Sex Outcome Treatment
1